NCIt related terms : PACLITAXEL DOCOSAHEXAENOIC ACID;
NCIt definition : A prodrug comprised of the naturally occurring omega-3 fatty acid docosahexaenoic
acid (DHA) covalently conjugated to the anti-microtubule agent paclitaxel. Because
tumor cells take up DHA, DHA-paclitaxel is delivered directly to tumor tissue, where
the paclitaxel moiety binds to tubulin and inhibits the disassembly of microtubules,
thereby resulting in the inhibition of cell division. Paclitaxel also induces apoptosis
by binding to and blocking the function of the apoptosis inhibitor protein Bcl-2 (B-cell
Leukemia 2). DHA-paclitaxel exhibits improved pharmacokinetic and toxicity profiles
when compared to conventional paclitaxel and has demonstrated antineoplastic activity
in animal models of cancer. (NCI04);
Alternative definition : NCI-GLOSS: A combination of DHA (a natural fatty acid) and paclitaxel (an anticancer
drug) being studied in the treatment of cancer. It is a type of mitotic inhibitor.;
UNII : OJE5810C4F;
CAS number : 73-67-6; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 73-67-6
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;